Maternal serum free-β-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13+6 weeks in relation to co-variables in pregnant Saudi women

被引:18
作者
Ardawi, Mohammed-Salleh M.
Nasrat, Hasan A.
Rouzi, Abdulrahim A.
Qari, Mohammed H.
Al-Qahtani, Mohammed H.
Abuzenadah, Adel M.
机构
[1] King Abdulaziz Univ, Fac Med, Dept Clin Biochem, Jeddah 21465, Saudi Arabia
[2] King Abdulaziz Univ Hosp, Jeddah 21465, Saudi Arabia
[3] King Abdulaziz Univ, Fac Appl Med Sci, Dept Med Technol, Jeddah 21465, Saudi Arabia
[4] King Abdulaziz Univ, Genom Med Unit, Jeddah 21465, Saudi Arabia
关键词
first trimester; fetal nuchal translucency; maternal serum screening; co-variables;
D O I
10.1002/pd.1661
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Objective To establish normative values and distribution parameters of first-trimester screening markers, namely, fetal nuchal translucency (NT), maternal serum free beta-human chorionic gonadotrophin (beta-hCG) and pregnancy-associated plasma protein-A (PAPP-A), at 10 to 13(+6) weeks of gestation in Saudi women and to evaluate the effect of co-variables including maternal body weight, gravidity, parity, fetal gender, twin pregnancy, smoking and ethnicity on these markers. Methods A cohort of Saudi women (first cohort n = 1616) with singleton pregnancies prospectively participated in the present study, and fetal NT together with maternal serum free beta-hCG and PAPP-A were determined at 10 to 13(+6) weeks of gestation. The distribution of gestational age-independent multiples of the median (MoM) of the parameters was defined and normative values were established, and correction for maternal body weight was made accordingly. The influence of various co-variables was examined using the data collected from the first and the second (n = 1849) cohorts of women and 62 twin pregnancies, and compared with other studies. Results All markers exhibited log-normally distributed MoMs. Gestational age-independent normative values were established. Maternal body weight was corrected, particularly for maternal free beta-hCG and PAPP-A using standard methods. Fetal NT showed a negative relationship with increasing gravidity (r = -0.296) or parity (r = -0.311), whereas both free beta-hCG and PAPP-A exhibited a significant positive relationship. There was a significant increase in the MoM of free beta-hCG in female fetuses. Smoking decreased MoM values of free beta-hCG (by 14.6%; P < 0.01) and PAPP-A (by 18.8%; P < 0.001). Twin pregnancy showed significant increases in MoM values of free beta-hCG (by 1.87-fold) and PAPP-A (by 2.24-fold), with no significant changes in fetal NT MoM values. Fetal NT MoM values were lower in Africans and Asians but higher in Orientals, as compared to Saudi women (P < 0.05; in each case). MoM values (body weight-corrected) of free beta-hCG were 25.2% higher in Africans and 19.4% higher in Orientals but 6.8% lower in other Arabian and Asian (by 5.8%) women as compared to Saudi women (P < 0.05; in each case). Conclusions The normative values and distribution parameters for fetal NT, maternal serum free beta-hCG and PAPP-A were established in Saudi singleton pregnancies, the maternal body weight together with smoking, twin pregnancy and ethnicity being important first-trimester screening co-variables. Gravidity, parity and fetal gender are also considered to influence one or more of the first-trimester markers examined. Copyright (c) 2007 John Wiley & Sons, Ltd.
引用
收藏
页码:303 / 311
页数:9
相关论文
共 84 条
[71]  
Tsukerman GL, 1999, PRENATAL DIAG, V19, P499, DOI 10.1002/(SICI)1097-0223(199906)19:6<499::AID-PD555>3.0.CO
[72]  
2-6
[73]  
Tul N, 1999, PRENATAL DIAG, V19, P1035, DOI 10.1002/(SICI)1097-0223(199911)19:11<1035::AID-PD694>3.0.CO
[74]  
2-2
[75]   First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS) [J].
Wald, NJ ;
Rodeck, C ;
Hackshaw, AK ;
Walters, J ;
Chitty, L ;
Mackinson, AM .
JOURNAL OF MEDICAL SCREENING, 2003, 10 (02) :56-104
[76]   Advances in antenatal screening for Down Syndrome [J].
Wald, NJ ;
Hackshaw, AK .
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2000, 14 (04) :563-580
[77]   First-trimester screening for trisomies 21 and 18 [J].
Wapner, R ;
Thom, E ;
Simpson, JL ;
Pergament, E ;
Silver, R ;
Filkins, K ;
Platt, L ;
Mahoney, M ;
Johnson, A ;
Hogge, WA ;
Wilson, RD ;
Mohide, P ;
Hershey, D ;
Krantz, D ;
Zachary, J ;
Snijders, R ;
Greene, N ;
Sabbagha, R ;
MacGregor, S ;
Hill, L ;
Gagnon, A ;
Hallahan, T ;
Jackson, L .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (15) :1405-1413
[78]   First-trimester Down syndrome screening: Component analytes and timing for optimal performance [J].
Wenstrom, KD .
SEMINARS IN PERINATOLOGY, 2005, 29 (04) :195-202
[79]   Nuchal translucency measurements are highly correlated in both mono- and dichorionic twin pairs [J].
Wojdemann, KR ;
Larsen, SO ;
Shalmi, AC ;
Sundberg, K ;
Tabor, A ;
Christiansen, M .
PRENATAL DIAGNOSIS, 2006, 26 (03) :218-220
[80]   First trimester Down syndrome screening: Distribution of markers and comparison of assays for quantification of pregnancy-associated plasma protein-A [J].
Wojdemann, KR ;
Larsen, SO ;
Rode, L ;
Shalmi, A ;
Sundberg, K ;
Christiansen, M ;
Tabor, A .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2006, 66 (02) :101-111